D J Safer
Overview
Explore the profile of D J Safer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
746
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Safer D
CNS Drugs
. 2016 Aug;
7(4):264-72.
PMID: 27520752
The use of CNS stimulants for the treatment of attention deficit hyperactivity disorder (ADHD) in children has steadily increased in most areas of the world over the last 30 years....
2.
Safer D
J Youth Adolesc
. 2013 Dec;
15(5):405-17.
PMID: 24301864
An assessment of the stress of junior high/middle school (JH/MS) can be made by comparing overall behavior and academic student patterns in JH/MS with those in elementary school (ES), and...
3.
Safer D
J Child Adolesc Psychopharmacol
. 2009 Jul;
2(4):279-90.
PMID: 19630610
ABSTRACT The pertinent literature was reviewed on cardiovascular changes induced by psychostimulant medication treatment of hyperactive children. An assessment of 15 controlled studies using test doses of methylphenidate revealed a...
4.
Safer D, Zito J
Public Health
. 2007 Feb;
121(4):274-7.
PMID: 17316717
Investigators from a number of countries have linked temporal declines in the rate of completed suicide in children and adults to the increasing utilization of selective serotonin reuptake inhibitor (SSRI)...
5.
Zito J, Safer D
J Child Adolesc Psychopharmacol
. 2005 Mar;
15(1):5-9.
PMID: 15741780
No abstract available.
6.
dosReis S, Zito J, Safer D, Soeken K
Am J Public Health
. 2001 Jul;
91(7):1094-9.
PMID: 11441737
Objectives: This study assessed whether mental health services for youths differ with respect to medical assistance aid category. Methods: Computerized claims for 15,507 youths with Medicaid insurance in a populous...
7.
Zito J, Safer D
Biol Psychiatry
. 2001 Jun;
49(12):1121-7.
PMID: 11430854
Between 1988 and 1994, data from 3 large sites revealed a 3-5 fold increase in the prevalence of antidepressant (ATD) treatment for U.S. youths aged 2-19 years. In 1994, the...
8.
Safer D, Zito J, GARDNER J
J Am Acad Child Adolesc Psychiatry
. 2001 Jun;
40(6):622-9.
PMID: 11392339
Objective: To review the numerous reports of hepatotoxic adverse drug reactions (ADRs) ascribed to pemoline that were sent to the U.S. Food and Drug Administration (FDA) between 1975 and 1996...
9.
Zito J, Safer D
Curr Psychiatry Rep
. 2001 Mar;
3(2):115-25.
PMID: 11276406
This review of antidepressant treatments in children and adolescents emphasizes the gap between efficacy data derived from randomized clinical trials (RCTs) and the limited effectiveness data from community-based practices. Part...
10.
Safer D, Malever M
Pediatrics
. 2000 Sep;
106(3):533-9.
PMID: 10969099
Objective: A statewide school survey was performed to provide naturalistic data on the prevalence of medication administered to Maryland public school students for the treatment of attention deficit hyperactivity disorder...